KFA
UTMD icon

Krane Funds Advisors’s Utah Medical Products UTMD Stock Holding History

Krane Funds Advisors’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,662
Closed -$721K – 289
2020
Q1 		$721K Buy
7,662
+1,273
+20% +$118K 0.04% 41
2019
Q4 		$689K Buy
6,389
+354
+6% +$35.9K 0.04% 71
2019
Q3 		$578K Buy
6,035
+5,302
+723% +$493K 0.05% 83
2019
Q2 		$70K Buy
+733
New +$61.7K 0.01% 62

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Krane Funds Advisors's UTMD Position: Q2 2020 in Review

Krane Funds Advisors sold out of Utah Medical Products (UTMD) in Q2 2020, closing a stake of 7,662 shares — an estimated $721K sold.

Krane Funds Advisors first reported a position in UTMD in Q2 2019 and held it in 4 quarters. The position peaked at $721K in Q1 2020. 93 funds tracked by Wall St. Rank hold UTMD as of Q2 2020.

  • Krane Funds Advisors reported no remaining Utah Medical Products position as of Q2 2020 after selling out during the quarter.
  • Krane Funds Advisors sold 7,662 Utah Medical Products shares in Q2 2020, an estimated $721K.
  • Krane Funds Advisors first reported a position in Utah Medical Products in Q2 2019 and held it in 4 quarters.
  • Krane Funds Advisors's Utah Medical Products position peaked at $721K in Q1 2020.
  • 93 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2020.

Based on Krane Funds Advisors's 13F filing for Q2 2020, filed 10 Aug 2020.